PhD in Oncology

Qingdao University (QDU) is a comprehensive public university located in the coastal city of Qingdao. Formed through the consolidation of several institutions, QDU offers a broad portfolio of undergraduate and graduate programs spanning the sciences, engineering, medical sciences, social sciences and the humanities. Its seaside location provides a dynamic cultural setting and access to regional research collaborations.

The university hosts dozens of research centers and provincial key disciplines, supported by a large faculty that includes members of national academies and experienced scholars. QDU places emphasis on multidisciplinary research and international cooperation, with established partnerships across North America, Europe, Asia and Oceania. Graduate and doctoral programs are supported by well-equipped laboratories and engineering centers that enable applied research and innovation.

International students are accommodated in dorms equipped with private bathrooms and internet access, and campus services support academic and daily life. Exchange programs, scholarships and language courses are available to help students integrate academically and culturally. For students seeking a comprehensive university experience on China’s eastern seaboard, QDU offers a combination of strong academic programs, research opportunities and a welcoming campus environment.

The PhD in Oncology at Qingdao University is for students who want to study cancer and its effects. This 2-year PhD program is taught in English and helps students develop research skills.

The curriculum includes subjects like cancer biology and research methods. Students will develop skills in data analysis and critical thinking, and will have hands-on experience with lab work and research projects.

Graduates can work as Research Scientists, Clinical Trials Managers, or Oncology Specialists in hospitals, research institutions, or pharmaceutical companies. They can also work as Medical Writers or Healthcare Consultants, helping to develop new treatments and improve patient care.